MX2017006227A - Sistema de administración de óxido nítrico y métodos de uso. - Google Patents
Sistema de administración de óxido nítrico y métodos de uso.Info
- Publication number
- MX2017006227A MX2017006227A MX2017006227A MX2017006227A MX2017006227A MX 2017006227 A MX2017006227 A MX 2017006227A MX 2017006227 A MX2017006227 A MX 2017006227A MX 2017006227 A MX2017006227 A MX 2017006227A MX 2017006227 A MX2017006227 A MX 2017006227A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- delivery system
- nitric oxide
- subject
- gno
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/30—Gas therapy for therapeutic treatment of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0266—Nitrogen (N)
- A61M2202/0275—Nitric oxide [NO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/20—Pathogenic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/20—Pathogenic agents
- A61M2202/203—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/20—Pathogenic agents
- A61M2202/206—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3327—Measuring
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Modalidades de la presente descripción proporcionan sistemas y dispositivos para administrar Óxido Nítrico gaseoso (gNO) bajo parámetros terapéuticos para reducir infección en un sujeto. Ciertas modalidades incluyen dispositivos y sistemas para administrar gNO presurizado para reducir carga bacteriana biológica y promover curación en las heridas de sujetos que tienen condiciones de enfermedad, que incluyen, pero no se limitan a, infecciones de la piel y tejidos blandos (SSTI) y osteomielitis. En algunas modalidades, la presente descripción proporciona dispositivos portátiles de curación de heridas para administrar Gno presurizado al sitio de una herida para tratar diferentes condiciones de enfermedad en un sujeto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462079461P | 2014-11-13 | 2014-11-13 | |
PCT/US2015/060461 WO2016077635A1 (en) | 2014-11-13 | 2015-11-12 | Nitric oxide delivery system and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017006227A true MX2017006227A (es) | 2018-02-09 |
Family
ID=54704119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017006227A MX2017006227A (es) | 2014-11-13 | 2015-11-12 | Sistema de administración de óxido nítrico y métodos de uso. |
Country Status (6)
Country | Link |
---|---|
US (1) | US10391266B2 (es) |
EP (1) | EP3218042A1 (es) |
AU (1) | AU2015346202A1 (es) |
CA (1) | CA2967802A1 (es) |
MX (1) | MX2017006227A (es) |
WO (1) | WO2016077635A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11524127B2 (en) * | 2019-11-25 | 2022-12-13 | Beyond Air, Inc. | System and method for delivery of gas to a tissue |
JP2023524152A (ja) * | 2020-05-04 | 2023-06-08 | フィッシャー アンド ペイケル ヘルスケア リミテッド | 創縁拡散器 |
USD1011523S1 (en) | 2021-09-27 | 2024-01-16 | Fisher & Paykel Healthcare Limited | Surgical gas diffuser |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2254645A1 (en) | 1998-11-23 | 2000-05-23 | Pulmonox Medical Corporation | Method and apparatus for treatment of respiratory infections by nitric oxide inhalation |
US6432077B1 (en) | 2000-12-26 | 2002-08-13 | Sensormedics Corporation | Device and method for treatment of surface infections with nitric oxide |
US7122018B2 (en) * | 2000-12-26 | 2006-10-17 | Sensormedics Corporation | Device and method for treatment of wounds with nitric oxide |
US20020155164A1 (en) * | 2001-04-18 | 2002-10-24 | Curtis Figley | System and method for the prevention of infections in human patients using nitric oxide |
DE10335732A1 (de) * | 2003-08-05 | 2005-02-24 | Daimlerchrysler Ag | Verfahren zum Ändern des Beschleunigungsmodus eines Kraftfahrzeugs |
EP1755715A4 (en) | 2004-05-11 | 2010-03-24 | Sensormedics Corp | INTERMITTENT DETERMINATION OF GASEOUS NITRIC OXIDE |
US20060191535A1 (en) * | 2005-02-25 | 2006-08-31 | The Nemours Foundation | Treatment of decompression sickness with inhaled nitric oxide gas |
US20080193566A1 (en) * | 2007-02-09 | 2008-08-14 | Miller Christopher C | Use of high dose concentrations of gaseous nitric oxide |
US20090216204A1 (en) * | 2008-02-27 | 2009-08-27 | Sai Bhavaraju | Auto-replenishing, wound-dressing apparatus and method |
WO2010014818A1 (en) | 2008-07-30 | 2010-02-04 | Nitric Biotherapeutics, Inc. | Methods of treating an infection with nitric oxide |
JP5736383B2 (ja) * | 2009-10-23 | 2015-06-17 | アミール ベルソン, | 可搬性局所的酸素療法システム |
EP2552508A2 (en) * | 2010-03-31 | 2013-02-06 | Koninklijke Philips Electronics N.V. | Wound care system |
US9364388B2 (en) * | 2012-09-27 | 2016-06-14 | Barry university | Methods of treatment with nitric oxide at pressures greater than one atmosphere |
US20160137968A1 (en) | 2014-11-13 | 2016-05-19 | Barry university | Tissue culture testing systems and methods of use |
-
2015
- 2015-11-12 AU AU2015346202A patent/AU2015346202A1/en not_active Abandoned
- 2015-11-12 MX MX2017006227A patent/MX2017006227A/es unknown
- 2015-11-12 WO PCT/US2015/060461 patent/WO2016077635A1/en active Application Filing
- 2015-11-12 CA CA2967802A patent/CA2967802A1/en not_active Abandoned
- 2015-11-12 EP EP15801060.3A patent/EP3218042A1/en not_active Withdrawn
- 2015-11-12 US US14/939,995 patent/US10391266B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2016077635A1 (en) | 2016-05-19 |
US10391266B2 (en) | 2019-08-27 |
EP3218042A1 (en) | 2017-09-20 |
US20160136364A1 (en) | 2016-05-19 |
CA2967802A1 (en) | 2016-05-19 |
AU2015346202A1 (en) | 2017-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021004546A (es) | Composiciones de suministro de farmaco implantables y metodos de uso de las mismas. | |
MX2015012322A (es) | Uso de levocetirizina y montelukast en el tratamiento de trastornos autoinmunes. | |
MX2012014521A (es) | Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado comun e inflamacion. | |
MX2016010532A (es) | Sistemas y metodos para cicatrizacion de tejido. | |
MX2016005532A (es) | Metodos para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades. | |
WO2014153473A3 (en) | Methods and apparatus for reducing the risk of surgical site infections | |
MX2017017138A (es) | Conjugados homogeneos especificos de sitio con inhibidores de ksp. | |
MX2015012315A (es) | Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica. | |
WO2014164285A3 (en) | Use of levocetirizine and montelukast in the treatment of vasculitis | |
MX2015011775A (es) | Uso de levocetirizina y montelukast en el tratamiento de anafilaxis. | |
SA519400913B1 (ar) | تركيبة موضعية لتعزيز إلتئام الجروح | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
PH12017500392A1 (en) | Medical treatments based on anamorelin | |
MX2017006227A (es) | Sistema de administración de óxido nítrico y métodos de uso. | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
MX2018005876A (es) | Regimen de dosificacion de plasminogeno para la cicatrizacion de heridas. | |
BR112015028334A2 (pt) | agente e método para o tratamento de herpes | |
MX2020004518A (es) | Suministro asistido de manera magnética al interior y a través de la piel. | |
Girard | Evidence appraisal of Harman S, Zemek R, Duncan MJ, Ying Y, Petrcich W. Efficacy of pain control with topical lidocaine-epinephrine-tetracaine during laceration repair with tissue adhesive in children: a randomized controlled trial. CMAJ. 2013; 185 (13): E629-E634 | |
UA120024U (uk) | Спосіб консервативного лікування гнійних ран у хворих з флегмонами підщелепної ділянки | |
MD757Y (en) | Method for treating burns of I...IIIB degree | |
AR106220A1 (es) | Conjugados homogéneos específicos de sitio con inhibidores de ksp | |
ITSI20120004U1 (it) | Cerotto sterile monouso per accelerare la guarigione di ferite e piaghe usando l'ossigenoterapia in uso locale su ogni parte del corpo. | |
GB201501717D0 (en) | Galactose polymer gel dressing for wound healing and as a means of passive or active transdermal delivery of remedial agents | |
UA64165U (ru) | Способ лечения пациентов с травмами мягких тканей конечностей |